CGX vs. WILD, ZUM, CCA, CGO, RAY.A, Y, PNC.B, EQ, FORA, and AXV
Should you be buying Cineplex stock or one of its competitors? The main competitors of Cineplex include WildBrain (WILD), ZoomerMedia (ZUM), Cogeco Communications (CCA), Cogeco (CGO), Stingray Group (RAY.A), Yellow Pages (Y), Postmedia Network Canada Corp Class NC (PNC.B), EQ (EQ), VerticalScope (FORA), and Axion Ventures (AXV). These companies are all part of the "communication services" sector.
Cineplex vs. Its Competitors
Cineplex (TSE:CGX) and WildBrain (TSE:WILD) are both small-cap communication services companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, risk, analyst recommendations, media sentiment, profitability, valuation and dividends.
In the previous week, Cineplex and Cineplex both had 1 articles in the media. Cineplex's average media sentiment score of 0.67 beat WildBrain's score of 0.36 indicating that Cineplex is being referred to more favorably in the media.
Cineplex has a beta of 2.74, indicating that its stock price is 174% more volatile than the S&P 500. Comparatively, WildBrain has a beta of 0.87, indicating that its stock price is 13% less volatile than the S&P 500.
Cineplex pays an annual dividend of C$1.80 per share and has a dividend yield of 17.3%. WildBrain pays an annual dividend of C$0.08 per share and has a dividend yield of 4.4%. Cineplex pays out -302.9% of its earnings in the form of a dividend. WildBrain pays out -9.3% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Cineplex is clearly the better dividend stock, given its higher yield and lower payout ratio.
Cineplex has higher revenue and earnings than WildBrain. Cineplex is trading at a lower price-to-earnings ratio than WildBrain, indicating that it is currently the more affordable of the two stocks.
24.3% of Cineplex shares are owned by institutional investors. Comparatively, 45.4% of WildBrain shares are owned by institutional investors. 1.9% of Cineplex shares are owned by insiders. Comparatively, 1.3% of WildBrain shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
Cineplex currently has a consensus target price of C$13.08, indicating a potential upside of 25.80%. WildBrain has a consensus target price of C$1.88, indicating a potential upside of 4.63%. Given Cineplex's stronger consensus rating and higher probable upside, equities analysts plainly believe Cineplex is more favorable than WildBrain.
Cineplex has a net margin of -2.83% compared to WildBrain's net margin of -38.77%. WildBrain's return on equity of 3,013.26% beat Cineplex's return on equity.
Summary
Cineplex beats WildBrain on 12 of the 17 factors compared between the two stocks.
Get Cineplex News Delivered to You Automatically
Sign up to receive the latest news and ratings for CGX and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding CGX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Cineplex Competitors List
Related Companies and Tools
This page (TSE:CGX) was last updated on 8/8/2025 by MarketBeat.com Staff
